Unrecognized potential of surviving neurons: Within-systems plasticity, recovery of function, and the hypothesis of minimal residual structure

Neuroscientist

Volumn 3, Issue 6, 1997, Pages 366-370

  Sabel, Bernhard A ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Plasticity; Recovery; Visual system

Indexed keywords

EID: 0001336527     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/107385849700300609     Document Type: Review

References (35)

1. Freund H-J, Sabel BA, Witte OW, editors. Brain plasticity: advances in neurology. Vol. 73. Philadelphia: Lippincott-Raven; 1997.
2. Finger S, LeVere TE, Almli CR, Stein DG, editors. Brain injury and recovery. New York: Plenum; 1988.
3. Finger S, editor. Recovery from brain damage. New York: Plenum; 1978.
4. Kaas JH. Plasticity of sensory and motor maps in adults mammals. Annu Rev Neurosci 1991;14:137-167.
5. Frackowiak RSJ. Plasticity and the human brain: insights from functional imaging. NEUROSCIENTIST 1996;2:353-362.
6. Sabel BA, Kasten E, Kreutz MR. Recovery of vision after partial visual system injury as a model of neuroplasticity. Adv Neurol 1997;73:251-276.
7. Sautter J, Sabel BA. Recovery of vision despite progressive loss of retrogradely labelled retinal ganglion cells after optic nerve crush. Eur J Neurosci 1993;5:680-690.
8. Duvdevani R, Rosner M, Belkin M, Sautter J, Sabel BA, Schwartz M. Graded crush of the rat optic nerve as a brain injury model: combining electrophysiological and behavioral outcome. Restor Neurol Neurosci 1990;2:31-38.
9. Sabel B, Sautter J, Stoehr T, Siliprandi R. A behavioral model of excitotoxicity: retinal degeneration, loss of vision, and subsequent recovery after intraocular NMDA-administration in adult rats. Exp Brain Res 1995;106:93-105.
10. Sabel BA, Engelmann R, Humphrey MM. In vivo confocal neuroimaging of CNS neurons (ICON). Nature Medicine 1997; 3:244-247.
11. Kreutz MR, Böckers TM, Bockmann J, Weise J, Schmitt U, Sabel BA. NMDA R1 splicing is altered in the retinal ganglion cell layer after optic nerve crush [abstract]. In: Proceedings and abstracts of the Annual Meeting of the Society for Neuroscience; 1995:308.7.
12. Weise J, Kreutz MR, Böckers TM, Seidenbecher C, Sabel BA. Changes in retinal bFGF expression following controlled optic nerve crush [abstract]. In: Proceedings and abstracts of the Annual Meeting of the Society for Neuroscience; 1996:222.13.
13. Finklestein SP, Fanning PJ, Caday CG, et al. Increased levels of basic fibroblast growth factor (bFGF) following focal brain injury. Restor Neurol Neurosci 1990;1:387-395.
14. Sakaguchi T, Yamada K, Wanaka A, et al. Expression of basic fibroblast growth factor receptor messenger RNA in the periinfarcted brain tissue. Restor Neurol Neurosci 1994,7:29-36.
15. Schmitt U, Cross R, Pazdernik TL, Sabel BA. Loss and subsequent recovery of local cerebral glucose use in visual targets after controlled optic nerve crush in adult rats. Exp Neurol 1996;139:17-24.
16. Weise J, Kreutz MR, Böckers TM, Humphrey MC, Sabel BA. Retinal NMDA-toxicity alters retino-tectal projections in the rat [abstract]. In: Proceedings and abstracts of the Annual Meeting of the Society for Neuroscience; 1995:328.4.
17. Kasten E, Sabel BA. Visual field enlargement after computer-training in brain damaged patients with homonymeous deficits - an open pilot trial. Restor Neurol Neurosci 1995;8:113-127.
18. Pommerenke K, Markowitsch HJ. Rehabilitation training of homonymous visual field defects in patients with postgeniculate damage of the visual system. Restor Neurol Neurosci 1989;1:47-65.
19. Clark RE, Delay ER. Reduction of lesion-induced deficits in visual reversal learning following cross-modal training. Restor Neurol Neurosci 1991;3:247-257.
20. Kerkhoff G, Münbinger U, Haaf E, Eberle-Strauss G, Stögerer E. Rehabilitation of homonymous scotoma in patients with postgeniculate damage of the visual system: saccadic compensation training. Restor Neurol Neurosci 1992;4:245-255.
21. Castaneda E, Wishaw IQ, Robinson TE. Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size. J Neurosci 1990;10:1847-1854.
22. Hornykiewicz O, Kish SJ. Biochemical pathophysiology of Parkinson's disease, Adv Neurol 1986;45:19-32.
23. Lindvall O. Neuronal transplantation in Parkinson's disease. In: Dunnett SB, Björklund A, editors. Functional neural transplantation. New York: Raven Press; 1994. p. 103-137.
24. Nakao N, Frodl EM, Duan WM, Widner H, Brundin P. Lazaroids improve the survival of grafted rat embryonic dopamine neurons. PNAS 1994;91:12408-12412.
25. Basso DM, Beattie MS, Breshnahan JC. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 1996;139:244-256.
26. Beattie MS, Leedy MG, Breshnahan JC. Evidence for alterations of synaptic inputs to sacral spinal reflex circuits after spinal cord transection in the cat. Exp Neurol 1993;123:35-50.
27. Eysel UT. Perilesional cortical dysfunction and reorganization. Adv Neurol 1997;73:195-206.
28. Yamasaki DS, Wurtz RH. Recovery of function after lesions in the superior temporal sulcus in the monkey. J Neurophysiol 1991;66:651-673.
29. Seitz RJ, Freund H-J. Plasticity of the human motor cortex. Adv Neurol 1997;73: 321-333.
30. Weiller C, Isensee C, Rijntjes M, et al. Recovery from Wernicke's aphasia: a positron emission tomography study. Ann Neurol 1995;37:723-732.
31. Price C, Warburton E, Swinburn K, Wise RJS, Frackowiak RSJ. Monitoring the recovery of aphasia using positron emission tomography. J Cereb Blood Flow Metab 1995;15(Suppl):S696.
32. DiPiero V, Chollet FM, MacCarty P, Lenzi GL, Frackowiak RS. Motor recovery after acute stroke: a metabolic study. J Neurol Neurosurg Psychiatry 1992;55: 990-996.
33. Goldstein LB, Davis JN. Post-lesion practice and amphetamine-facilitated recovery of beam-walking in the rat. Restor Neurol Neurosci 1990;1:311-315.
34. Schmitt U, Sabel BA. Basic fibroblast growth factor treatment protects from visual deficits but docs not increase retinal ganglion cell survival following controlled optic nerve crush. Restor Neurol Neurosci 1996;10:61-68.
35. Freed WJ. Substantia nigra grafts and Parkinson's disease: from animal experiments to human therapeutic trials. Restor Neurol Neurosci 1991;3:109-135.